National Institutes of Health, National Cancer Institute, Division of Extramural Activities - Home Page
NIH NCI DEA Logo NIH NCI NCI/DEA
Active NCI RFAs:  FY 2021  FY 2020  FY 2019 | Archive RFAs | Active PAs
Current and Recent Requests for Applications (RFA's)
RFA's that are active or have expired within the last 3 months (and associated notices)
 
2021 Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
CA21-019 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)ACTIVE - NOV 19, 2021
CA21-018 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)ACTIVE - NOV 18, 2021
CA21-017 Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)ACTIVE - NOV 18, 2021
CA21-016 Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)ACTIVE - NOV 18, 2021
CA21-015 Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)ACTIVE - NOV 18, 2021
CA21-014 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)ACTIVE - NOV 18, 2021
CA21-013 Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)ACTIVE - NOV 18, 2021
CA21-012 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)ACTIVE - SEP 30, 2021
CA21-011 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)ACTIVE - SEP 30, 2021
CA21-010 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)ACTIVE - SEP 30, 2021
CA21-009 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)ACTIVE - SEP 30, 2021
CA21-008 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)ACTIVE - SEP 30, 2021
CA21-007 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)ACTIVE - SEP 30, 2021
CA21-006 Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)ACTIVE - SEP 30, 2021
CA21-005 Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)ACTIVE - SEP 30, 2021
CA21-004 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)ACTIVE - SEP 29, 2021
CA21-003 Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)ACTIVE - SEP 30, 2021
CA21-002 Cellular Cancer Biology Imaging Research (CCBIR) Program (U54, Clinical Trial Not Allowed)ACTIVE - MAR 19, 2021
CA21-001 Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)ACTIVE - MAR 11, 2021
 
2021 Trans-NIH Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
DA21-009 Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional)EXPIRED - OCT 20, 2020
HD21-002 Centers to Advance Research in Endometriosis (CARE) (P01 Clinical Trial Not Allowed)EXPIRED - DEC 01, 2020
 
 
 
 
2020 Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
CA20-057 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required)ACTIVE - FEB 27, 2021
CA20-056 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Not Allowed)ACTIVE - FEB 27, 2021
CA20-055 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)ACTIVE - FEB 27, 2021
CA20-054 Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed)EXPIRED - JAN 16, 2021
CA20-053 Genomic Data Analysis Network: Genomic Data Analysis Center (U24 Clinical Trial Not Allowed)EXPIRED - NOV 13, 2020
CA20-052 Limited Competition: Childhood Cancer Survivor Study (U24 Clinical Trial Required)EXPIRED - NOV 19, 2020
CA20-051 Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)ACTIVE - JAN 19, 2022
CA20-050 New Cohorts for Environmental Exposures and Cancer Risk (CEECR) Coordinating Center (U24 Clinical Trial Not Allowed)ACTIVE - JAN 30, 2021
CA20-049 New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed)ACTIVE - JAN 30, 2021
CA20-048 The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)EXPIRED - NOV 19, 2020
CA20-047 Glioblastoma Therapeutics Network (U19 Clinical Trial Required)EXPIRED - NOV 20, 2020
CA20-046 Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)ACTIVE - DEC 15, 2021
CA20-045 Limited Competition: International Agency for Research on Cancer (IARC) Monographs Program (R01 Clinical Trial Not Allowed)EXPIRED - DEC 17, 2020
CA20-044 Visualization Methods and Tools Development for Enhancing Cancer Moonshot Data (R33 Clinical Trial Not Allowed)EXPIRED - OCT 31, 2020
CA20-043 Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed)ACTIVE - JAN 21, 2021
CA20-042 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)EXPIRED - NOV 10, 2020
CA20-041 NCI Pediatric In Vivo Testing Program Coordinating Center (U24 Clinical Trial Not Allowed)EXPIRED - NOV 10, 2020
CA20-040 Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)ACTIVE - FEB 18, 2021
CA20-034 NCI Pediatric In Vivo Testing Program (U01 Clinical Trial Not Allowed)EXPIRED - NOV 10, 2020
CA20-031 Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)ACTIVE - JUN 25, 2021
CA20-029 Metastasis Research Network (U54 Clinical Trial Not Allowed)ACTIVE - MAY 29, 2021
CA20-028 Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional)ACTIVE - JUL 31, 2021
CA20-027 Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional)ACTIVE - JUL 31, 2021
CA20-013 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)EXPIRED - NOV 19, 2020
CA20-012 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)EXPIRED - NOV 19, 2020
CA20-011 Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)EXPIRED - NOV 19, 2020
CA20-010 Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)EXPIRED - NOV 19, 2020
CA20-009 Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)EXPIRED - NOV 19, 2020
CA20-008 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)EXPIRED - NOV 19, 2020
CA20-007 Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)EXPIRED - NOV 19, 2020
CA20-005 Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)EXPIRED - NOV 18, 2020
CA20-004 Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)EXPIRED - NOV 18, 2020
 
2020 Trans-NIH Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
ES20-018 Utilizing In Vitro Functional Genomics Advances for Gene-Environment (G x E) Discovery and Validation (R01 Clinical Trial Not Allowed)ACTIVE - FEB 02, 2021
HG20-048 Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01, Clinical Trial Optional)ACTIVE - JUL 09, 2021
HL20-006 Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)ACTIVE - JAN 15, 2022
NS20-011 HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)ACTIVE - SEP 09, 2022
NS20-010 HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)ACTIVE - SEP 09, 2022
NS20-009 HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)ACTIVE - SEP 09, 2022
NS20-008 HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)ACTIVE - SEP 09, 2022
OD20-011 Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required)ACTIVE - JUL 11, 2022
OD20-010 Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required)ACTIVE - JUL 11, 2022
OD20-009 Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)ACTIVE - JUL 11, 2022
OD20-008 Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)ACTIVE - JUL 11, 2022
 
 
 
 
2019 Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
CA19-053 Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed)ACTIVE - JUN 24, 2021
CA19-052 Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed)ACTIVE - JUN 24, 2021
CA19-051 Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed)ACTIVE - JUN 24, 2021
CA19-050 Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed)ACTIVE - JUN 24, 2021
CA19-049 Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed)ACTIVE - JUN 24, 2021
CA19-045 Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional)EXPIRED - OCT 31, 2020
CA19-034 Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional)EXPIRED - OCT 19, 2020
 
2019 Trans-NIH Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
OD19-028 Tobacco Regulatory Science (R01 Clinical Trial Optional)ACTIVE - FEB 14, 2021
OD19-022 Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)ACTIVE - MAR 09, 2021
OD19-021 Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed)ACTIVE - MAR 09, 2021